Cigna Infliximab Users Get $500 To Switch To Biosimilars

Remicade Users Receive $500 Debit Card To Move Onto Preferred Drugs From Amgen And Pfizer

Program aims to share rebate savings from preferred drugs, ease treatment disruptions. Products like Remicade covered under medical benefits require new kinds of incentives for switching.

Insurer's Program Aims To Switch Patients From Remicade • Source: Alamy

More from Drug Pricing

More from Policy & Regulation